Shionogi Covid Pill May Get China Approval in March: CEO

The video discusses the joint venture between Piang Shionogi and PNC in China, focusing on the development and distribution of a COVID compound. It highlights partnerships with Shanghai Pharmaceutical and Agenda Pharmaceutical for distribution. The video also details the production capacity of API facilities and tablets, and discusses the approval process with Chinese health authorities, aiming for approval in the first quarter of 2023.

What partnerships were announced for the distribution of the COVID pill in China?

What challenges are mentioned regarding the approval process in China?